Enrico C. Lallana

Ibrutinib Unmasks Critical Role of Bruton Tyrosine Kinase in Primary CNS Lymphoma

Christian Grommes, Alessandro Pastore, Nicolaos Palaskas et al. · Cancer Discovery · 2017 · 402 citations · Full text

Medicine, Oncology, Pharmacology +16

NRG Oncology/RTOG1205: A Randomized Phase II Trial of Concurrent Bevacizumab and Reirradiation Versus Bevacizumab Alone as Treatment for Recurrent Glioblastoma

Christina Tsien, Stephanie L. Pugh, Adam P. Dicker et al. · Journal of Clinical Oncology · 2022 · 199 citations · Full text

Medicine, Oncology, Radiation Oncology +16

Immune Response in Patients With Newly Diagnosed Glioblastoma Multiforme Treated With Intranodal Autologous Tumor Lysate-dendritic Cell Vaccination After Radiation Chemotherapy

Camilo E. Fadul, Jan L. Fisher, Thomas H. Hampton et al. · Journal of Immunotherapy · 2011 · 175 citations

Medicine, Immunology, Oncology +17

Alemtuzumab improves preexisting disability in active relapsing-remitting MS patients

Gavin Giovannoni, Jeffrey Cohen, Alasdair Coles et al. · Neurology · 2016 · 62 citations · Full text

Medicine, Neurology, Pharmacotherapy +13

Randomized phase II study of rituximab, methotrexate (MTX), procarbazine, vincristine, and cytarabine (R-MPV-A) with and without low-dose whole-brain radiotherapy (LD-WBRT) for newly diagnosed primary CNS lymphoma (PCNSL).

Antonio Omuro, Lisa M. DeAngelis, Theodore Karrison et al. · Journal of Clinical Oncology · 2020 · 59 citations

Medicine, Oncology, Pharmacology +7